Lyterian Therapeutics
Quang Luu Nguyen is a highly skilled chemist with extensive research and teaching experience. Currently serving as a Senior Scientist at Lyterian Therapeutics since July 2023, Quang previously held positions as Scientist II and Scientist I at REVOLUTION Medicines from April 2021 to June 2023. Quang's academic background includes a Ph.D. in Chemistry from Stanford University, where research focused on Protein Kinase C activators aimed at innovative treatments for diseases such as HIV/AIDS, cancer, and Alzheimer's. Additionally, Quang contributed to education as a Graduate Teaching Assistant and an undergraduate Teaching Assistant at Stanford University and the University of Minnesota, respectively, enhancing students' understanding of complex chemistry concepts and experimental techniques. Prior research involvement includes the Hexadehydro-Diels-Alder Reaction Project at the University of Minnesota and supporting students as a Peer Learning Consultant in chemistry, physics, and math.
This person is not in any offices
Lyterian Therapeutics
1 followers
Lyterian Therapeutics derives its name from the Greek word λυτήριος or lutḗrios, that defines the termination, healing, or end of disease. Disease resolution is coordinated by endogenous and exogenous agents that recruit cells and other effectors to the site of injury. We are inspired to learn from the logic that orchestrates homeostatic equilibria and fosters healing in response to disease. At Lyterian Therapeutics, we are committed to developing medicines for patients in need by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically validated targets.
Employees
1-10